Surge of generic weight-loss drugs triggers price war in India
Open this photo in gallery: Obesity doctor and consultant Swati Pradhan explains the Mounjaro GLP-1 self-injectable device at…
GLP-1 drugs reshape alcohol consumption and hospitality habits
Millions of Britons using GLP-1 weight loss medications are beginning to alter how they drink, dine and choose…
All about new ‘triple-G’ drug that’s helped patients lose a quarter of their body weight
G whiz! The latest experimental GLP-1 from Eli Lilly isn’t just a diabetes drug — it also facilitates weight…
Large GLP-1 Drug Review Takes Closer Look at Risks, Rewards
Moderate- to high-quality evidence from an umbrella review on non-cardiometabolic outcomes reinforced links between GLP-1 therapies and risks…
FDA Approves Eli Lilly’s GLP-1 Pill
The US Food and Drug Administration on Wednesday approved a new obesity pill called Foundayo. Taken once daily,…
DC dietician raises concerns over compounded GLP-1 weight-loss medications
As GLP-1 medications grow in popularity not just for treating diabetes but also for weight loss, some people…
Creatine Brand Create Wellness Raises $20 Million In Fresh Funding
Create Wellness launched on Monday a Creatine + Electrolyte mix that will be available on Create’s website, Amazon,…
Jacksonville research group exploring new paths to lasting weight loss beyond GLP-1 drugs
JACKSONVILLE, Fla. – For some, GLP-1 drugs feel like a weight-loss miracle. For others, the weight comes right…
‘Substantial’ increase in fake or illegal weight-loss drugs seized by HPRA last year
We need your help now Support from readers like you keeps The Journal open. You are visiting us…
FDA approves new ‘Wegovy HD’ with triple the dosage of the semaglutide medication
The US Food and Drug Administration announced on Thursday its approval of a new, higher-dose Wegovy (semaglutide) injection.…
Semaglutide Falls Short in Alzheimer’s Phase 3 Trials
Phase 3 trials show oral semaglutide failed to slow early Alzheimer’s progression, potentially limiting its expansion beyond metabolic…
Ozempic is getting generics as low as $15 — what it means for Americans
The weight-loss world is on the brink of a major shake-up. Pharmaceutical companies in India will get the…